Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

PROCOVAXED: Promoting COVID vaccination in emergency departments

Researchers examine the reasons behind COVID-19 vaccine hesitancy emergency department patients when educated through vaccine messaging platforms.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

A recent study evaluated the effectiveness of lactobacilli throat sprays against COVID-19.

22 Mar 2022

How valid are the reported results on health outcomes in children after acute SARS-CoV-2 infection?

Researchers discussed the validity of reported health outcomes post-acute infection with SARS-CoV-2 in children.

22 Mar 2022

Immunocompromised patients worry vaccine exemptions put them in peril

Charlie O'Neill received part of her husband's liver in a 2013 living donor transplant and has been taking drugs that suppress her immune system ever since to prevent her body from attacking the organ.

22 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

In a recent study posted to the bioRxiv* preprint server, researchers conducted a phylogenetic investigation of the human parainfluenza type 3 virus strain (HPIV3) that caused an outbreak in South Korea amid the coronavirus disease 2019 (COVID-19) pandemic.

22 Mar 2022

Could COVID-19 spread through wastewater in the Thames?

Researchers investigate the presence of SARS-CoV-2 infectious particles and its RNA material in the Thames and other rivers.

21 Mar 2022

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

The immune system deteriorates with age, making COVID-19 particularly deadly in older people -; but to date, no clinically available medication addresses this key risk factor.

21 Mar 2022

IU researchers exploring new ways to treat seasonal or intermittent asthma

Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma.

21 Mar 2022

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published March 21 in Microbiology Spectrum, a journal of the American Society for Microbiology.

21 Mar 2022

Study explores prevalence and symptom trajectory of long COVID

A new study estimated long-term COVID-19, or, long COVID, and the trajectory of disease symptoms in a representative sample in the US.

21 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

David Sarabia had already sold two startups by age 26 and was sitting on enough money to never have to work another day in his life.

21 Mar 2022

Biological timeline of COVID-19 immune recovery described in new research

In a recent study published on the bioRxiv* preprint server, a group of researchers from the University of California, San Francisco, looked at intra-patient immunological changes over time to see if there were any changes in immune responses associated with successful COVID-19 resolution.

21 Mar 2022

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

A team of scientists from Turkey has recently evaluated the diversity and composition of gut microbiota in children diagnosed with multisystem inflammatory syndrome (MIS-C) and acute coronavirus disease 2019 (COVID-19). They have observed significant alteration in the gut microbiota composition in children with MIS-C. These changes are associated with autoimmunity, metabolic dysfunction, and obesity.

21 Mar 2022

Study links the usage of oral polio vaccines with lower incidence of COVID-19

A study published in the journal PLOS ONE showed how countries using oral polio vaccine have a lower incidence of coronavirus disease (COVID-19) when compared to those using inactivated polio vaccine – suggesting that the oral vaccine may either prevent the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the individual level or slow down the transmission in the community.

21 Mar 2022

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Researchers provide insight on the potentially significant impact of aerosol pH on the transmission of SARS-CoV-2.

20 Mar 2022

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

19 Mar 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

PROCOVAXED: Promoting COVID vaccination in emergency departments

Rubella antibodies vs. COVID-19

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

How valid are the reported results on health outcomes in children after acute SARS-CoV-2 infection?

Immunocompromised patients worry vaccine exemptions put them in peril

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

Could COVID-19 spread through wastewater in the Thames?

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

IU researchers exploring new ways to treat seasonal or intermittent asthma

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

Study explores prevalence and symptom trajectory of long COVID

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

Biological timeline of COVID-19 immune recovery described in new research

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

Study links the usage of oral polio vaccines with lower incidence of COVID-19

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in